Tetraphase Pharmaceuticals, Inc. approved the election of Dr. L. Patrick Gage and Ms. Nancy Wysenski as class I directors, each to serve for a three year term expiring at the 2017 annual meeting of stockholders at its annual meeting of stockholders held on June 12, 2014.
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+34.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.62% | 244B | |
+9.86% | 208B | |
-4.46% | 205B | |
+7.43% | 166B |